Regeneron Pharmaceuticals

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$3,754,300
$3,675,600
$3,028,700
$3,789,200
Gross Profit
3,232,700
3,145,400
2,564,400
3,223,800
EBITDA
1,919,300
1,657,400
1,040,600
1,095,000
EBIT
1,782,600
1,522,300
913,700
968,600
Net Income
1,460,000
1,391,600
808,700
917,700
Net Change In Cash
3,754,300
3,675,600
3,028,700
3,789,200
Free Cash Flow
1,417,300
967,600
773,600
995,800
Cash
2,506,400
1,995,800
3,090,200
2,488,200
Basic Shares
107,200
108,600
111,200
113,800

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$14,202,000
$13,117,200
$12,172,900
$16,071,700
Gross Profit
12,231,500
12,233,500
10,467,700
13,348,000
EBITDA
5,318,000
4,047,100
5,259,600
9,669,300
EBIT
4,835,100
4,047,100
4,918,200
9,383,100
Net Income
4,412,600
3,953,600
4,338,400
8,075,300
Net Change In Cash
14,202,000
13,117,200
12,172,900
16,071,700
Cost of Revenue
221,300
690,800
Free Cash Flow
3,664,600
3,667,600
4,424,800
6,529,400
Cash
2,488,200
2,730,000
3,105,900
2,885,600
Basic Shares
115,100
113,700
113,500
112,200

Earnings Calls

QuarterEPS
2025-12-31
$0
2025-09-30
$11.83
2025-06-30
$12.89
2025-03-31
$8.22